Localization of osteopontin at calcification sites of cholesteatoma: Possible role as a regulator of deposition of calcium phosphate in the middle ear

Auris Nasus Larynx

Volumn 31, Issue 1, 2004, Pages 3-9

  Makiishi Shimobayashi, Chiaki ^a   Tsujimura, Tohru ^a   Iwasaki, Teruo ^a   Kakihana, Michiko ^a   Shimano, Koichi ^a   Terada, Nobuyuki ^a   Sakagami, Masafumi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Cholesteatoma; Immunohistochemistry; In situ hybridization; Macrophage; OPN

Indexed keywords

CALCIUM PHOSPHATE; CD68 ANTIGEN; MESSENGER RNA; OSTEOPONTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCIFICATION; CHILD; CHOLESTEATOMA; CHRONIC OTITIS MEDIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; MACROPHAGE; MALE; MIDDLE EAR; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TYMPANOPLASTY;

ADOLESCENT; ADULT; AGED; CALCIUM PHOSPHATES; CHILD, PRESCHOOL; CHOLESTEATOMA; EAR, MIDDLE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGES; MALE; MIDDLE AGED; OSTEOPONTIN; PHOSPHOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALOGLYCOPROTEINS;

EID: 1642368922     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2003.11.010     Document Type: Article

References (14)

1. Anderson H.C. Normal and abnormal mineralization in mammals. Trans. Am. Soc. Artif. Intern. Organs. 27:1981;702-708.
2. Zollner F. Tympanosclerosis. J. Laryngol. Otol. 70:1956;77-85.
3. Sorensen H., True O. Histology of tympanosclerosis. Acta Otolaryngol. 73:1971;18-26.
4. Shimobayashi C., Tsujimura T., Sugihara A., Iwasaki T., Yamada N., Terada N.et al. Expression of osteopontin by exudate macrophages in inflammatory tissues of the middle ear: a possible association with development of tympanosclerosis. Hear Res. 153:2001;100-107.
5. Friedmann I. Pathology of the ear: selected topics. Pathol. Annu. 13:1978;363-410.
6. Sheehy J.L., House W.F. Tympanosclerosis. Arch. Otolaryngol. 76:1962;151-157.
7. Katagiri Y., Mori K., Hara T., Tanaka K., Murakami M., Uede T. Functional analysis of the osteopontin molecule. Ann. N.Y. Acad. 760:1995;371-374.
8. Falini B., Flenghi L., Pileri S. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted from the CD68 molecule. Am. J. Pathol. 142:1993;1359-1372.
9. Young M.F., Kerr J.M., Termine J.D., Wewer U.M., Wang M.G., McBride O.W.et al. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin. Genomics. 7:1990;491-502.
10. Wong H., Anderson W.D., Cheng T., Riabowol K.T. Monitoring mRNA expression by polymerase chain reaction: the 'primer-dropping' method. Anal. Biochem. 223:1994;251-258.
11. Jono S., Peinado C., Giachelli C.M. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J. Biol. Chem. 275:2000;20197-20203.
12. Hunter G.K., Kyle C.L., Goldberg H.A. Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem. J. 300:1994;723-728.
13. Oldberg A., Franzen A., Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell binding sequence. Proc. Natl. Acad. Sci. U.S.A. 83:1986;8819-8823.
14. 3 potentiate bone resorption. J. Biol. Chem. 268:1993;9901-9907.